Latest round: Growth. Chen Schor is the President and Chief Executive Officer of Adicet Bio, a clinical stage biotechnology company.
Chen Schor is the President and Chief Executive Officer of Adicet Bio, a clinical stage biotechnology company. Adicet Bio focuses on discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company recently reported its third-quarter 2025 financial results and announced positive preliminary data from its Phase 1 trial of ADI-001 for autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide